Journal
Clinical Cancer Research
Publication Date
8-1-2024
Volume
30
Issue
15
First Page
3220
Last Page
3228
Document Type
Open Access Publication
DOI
10.1158/1078-0432.CCR-23-3468
Rights and Permissions
ran D, Beeler JS, Liu J, Wiley B, Chan ICC, Xin Z, Kramer MH, Batchi-Bouyou AL, Zong X, Walter MJ, Petrone GEM, Chlamydas S, Ferraro F, Oh ST, Link DC, Busby B, Cao Y, Bolton KL. Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk. Clin Cancer Res. 2024 Aug 1;30(15):3220-3228. doi: 10.1158/1078-0432.CCR-23-3468 This open access article is distributed under the Creative Commons Attribution NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. ©2024 The Authors; Published by the American Association for Cancer Research
Recommended Citation
Tran, Duc; Beeler, J Scott; Liu, Jie; Wiley, Brian; Chan, Irenaeus C C; Xin, Zilan; Kramer, Michael H; Batchi-Bouyou, Armel L; Zong, Xiaoyu; Walter, Matthew J; Petrone, Giulia E M; Chlamydas, Sarantis; Ferraro, Francesca; Oh, Stephen T; Link, Daniel C; Busby, Ben; Cao, Yin; and Bolton, Kelly L, "Plasma proteomic signature predicts myeloid neoplasm risk." Clinical Cancer Research. 30, 15. 3220 - 3228. (2024).
https://digitalcommons.wustl.edu/oa_4/3951
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
